Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea

US Patent 8435970 · Granted May 7, 2013

Assignee

Inventors

View full patent text on Google Patents →